Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

November 6, 2025

Study Completion Date

November 6, 2025

Conditions
Multiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT)
Interventions
DRUG

Bortezomib

Maintenance: Administration as per routine clinical practice.

DRUG

Daratumumab

Maintenance: Administration as per routine clinical practice.

Trial Locations (32)

Unknown

RECRUITING

Hospital Universitario Del Sureste, Arganda

RECRUITING

Complejo Asistencial de Avila, Ávila

RECRUITING

Hospital Quirón Sagrado Corazón, Barcelona

RECRUITING

Hsopital Clinic de Barcelona, Barcelona

NOT_YET_RECRUITING

Hospital Universitario Virgen de Las Nieves, Granada

RECRUITING

Complejo Hospitalario de Jaén, Jaén

RECRUITING

Complejo Hospitalario Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria

RECRUITING

Hospital de León, León

NOT_YET_RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

RECRUITING

Hospital Ramón Y Cajal, Madrid

RECRUITING

Hospital Ruber Juan Bravo 39, Madrid

NOT_YET_RECRUITING

Hospital Universitario de La Princesa, Madrid

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

RECRUITING

Hospital Universitario Infanta Leonor, Madrid

RECRUITING

Hospital General Universitario J.M. Morales Meseguer, Murcia

RECRUITING

Complexo Hospitalario Universitario de Ourense, Ourense

RECRUITING

Hospital Universitario Central de Asturias, Oviedo

RECRUITING

Clinica Universidad de Navarra, Pamplona

RECRUITING

Hospital Virgen Del Puerto, Plasencia

RECRUITING

Hospital El Bierzo, Ponferrada

RECRUITING

Hospital Montecelo, Pontevedra

RECRUITING

Hospital Quirónsalud Madrid, Pozuelo de Alarcón

RECRUITING

Hospital Universitario de Salamanca, Salamanca

RECRUITING

Hospital Universitario de Canarias (H.U.C), San Cristóbal de La Laguna

RECRUITING

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

RECRUITING

Hospital Clinico Universitario de Santiago, Santiago de Compostela

NOT_YET_RECRUITING

Hospital General Nuestra Señora Del Prado, Talavera de la Reina

RECRUITING

Hospital Universitari Mútua de Terrassa, Terrassa

NOT_YET_RECRUITING

Hospital General de Tomelloso, Tomelloso

RECRUITING

Hospital Clinico Universitario de Valladolid, Valladolid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

collaborator

Adknoma Health Research

INDUSTRY

lead

PETHEMA Foundation

OTHER

NCT05218603 - Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT | Biotech Hunter | Biotech Hunter